Shire PLC (LON:SHP)‘s stock had its “overweight” rating reiterated by equities researchers at JPMorgan Chase & Co. in a research report issued to clients and investors on Monday.
Other research analysts also recently issued reports about the company. Shore Capital reiterated a “buy” rating on shares of Shire PLC in a report on Tuesday, August 30th. Deutsche Bank AG reiterated a “buy” rating and issued a GBX 6,000 ($73.13) price target on shares of Shire PLC in a report on Monday, September 19th. Goldman Sachs Group Inc. reiterated a “buy” rating and issued a GBX 6,300 ($76.78) price target on shares of Shire PLC in a report on Wednesday, October 12th. Credit Suisse Group AG reiterated an “outperform” rating and issued a GBX 5,200 ($63.38) price target on shares of Shire PLC in a report on Friday, October 7th. Finally, BNP Paribas reiterated an “outperform” rating and issued a GBX 5,900 ($71.91) price target on shares of Shire PLC in a report on Friday, September 30th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of GBX 5,907.50 ($72.00).
Shares of Shire PLC (LON:SHP) opened at 5140.00 on Monday. Shire PLC has a 52-week low of GBX 2,707.19 and a 52-week high of GBX 5,377.00. The company’s 50-day moving average price is GBX 5,022.47 and its 200-day moving average price is GBX 4,625.73. The stock’s market cap is GBX 35.10 billion.
The company also recently declared a dividend, which was paid on Friday, October 7th. Shareholders of record on Thursday, September 8th were given a dividend of GBX 3.51 ($0.04) per share. The ex-dividend date was Thursday, September 8th. This represents a yield of 0.07%.
In other news, insider Dominic Blakemore purchased 133 shares of the stock in a transaction on Friday, September 30th. The stock was bought at an average price of GBX 5,010 ($61.06) per share, with a total value of £6,663.30 ($8,121.02).
About Shire PLC
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.